FRONTEO has concluded a total loan contract of 1,220 million yen with Mitsubishi UFJ Bank, Sumitomo Mitsui Banking Corporation, and Resona Bank to accelerate the growth of its life science AI business, promoting business expansion and monetization.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2158","jir_company_name":"FRONTEO","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-24","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/2158-20260724-01.pdf","jir_short_summary":"FRONTEO has concluded a total loan contract of 1,220 million yen with Mitsubishi UFJ Bank, Sumitomo Mitsui Banking Corporation, and Resona Bank to accelerate the growth of its life science AI business, promoting business expansion and monetization.","jir_summary":"### Funding Overview\nFRONTEO has entered into a loan agreement totaling 1,220 million yen to accelerate growth in its life science AI business. The contracts were made with Mitsubishi UFJ Bank, Sumitomo Mitsui Banking Corporation, and Resona Bank, with the funds intended for R&D investments, organizational strengthening, and promotion of co-creation projects. This aims to monetize the business and achieve medium- to long-term expansion.\n\n### Future Outlook and Impact\nThe impact of this funding on the FY2027 performance is expected to be minor. FRONTEO will continue to promote growth strategies in its life science AI business, leveraging funding to enhance R&D and business expansion. The company will ensure stability and agility in funding to pursue sustained corporate value improvement.","jir_financial_highlights":"Total Borrowings: 1,220 million yen (Unknown)\nContract Period: July 24, 2026 \u2013 July 31, 2027 (Unknown)","jir_category":"","jir_hashtags":"#FRONTEO, #IR related, #Japanese Stocks","jir_key_figures":"Total Borrowings: 1,220 million yen\nContract Period: July 24, 2026 \u2013 July 31, 2027\nUse of Funds: R&D investments, organizational strengthening, promotion of co-creation projects","jir_meta_title":"[FRONTEO] Funding for the Life Science AI Business | July 2026","jir_meta_description":"FRONTEO has concluded a loan contract totaling 1,220 million yen to accelerate growth in its life science AI business.","jir_og_title":"[FRONTEO] AI Business Funding | July 2026","jir_og_description":"FRONTEO has completed funding to accelerate growth in its life science AI business, promoting business expansion and monetization.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57099,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-88035","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n